ETC
IOVA icon

Exchange Traded Concepts’s Iovance Biotherapeutics IOVA Stock Holding History

Exchange Traded Concepts’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-34,061
Closed -$113K – 1460
2025
Q1 		$113K Buy
34,061
+16,990
+100% +$87.6K ﹤0.01% 1115
2024
Q4 		$126K Hold
17,071
– – ﹤0.01% 1102
2024
Q3 		$160K Buy
17,071
+1,776
+12% +$16.8K ﹤0.01% 1040
2024
Q2 		$123K Sell
15,295
-4,757
-24% -$51K ﹤0.01% 929
2024
Q1 		$297K Sell
20,052
-6,551
-25% -$76.2K 0.01% 799
2023
Q4 		$216K Buy
26,603
+6,746
+34% +$35.3K 0.01% 783
2023
Q3 		$90.3K Buy
19,857
+3,777
+23% +$24.7K ﹤0.01% 936
2023
Q2 		$113K Buy
+16,080
New +$115K ﹤0.01% 927

Other funds holding IOVA

MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return